| Attachment | Size |
|---|---|
| PSYMP409.pdf | 755.32 KB |
Specialty Pharmaceutical Utilization Strategies for Use of Biologic Response Modifiers
TABLE OF CONTENTS
INTRODUCTION
The Role of Biologic Response Modifiers in Multiple Sclerosis Management Robert P. Navarro, PharmD
Role of Biologic Response Modifiers in Autoimmune Diseases and the Impact on Multiple Sclerosis: A Neurologist’s Perspective
Case Study 1 Jack Burks, MD
The Role and Utilization of Biologic Response Modifiers in Multiple Sclerosis: A Pharmacist’s Perspective
Case Study 2 Elizabeth Mauer, PharmD, MBA
Evidence-Based Medicine and Comparative Effectiveness Research: Toward Appropriate Utilization of Biopharmaceuticals in Multiple Sclerosis Thomas J. Bramley, RPh, PhD
2009-01-01
| Attachment | Size |
|---|---|
| PSYMP409.pdf | 755.32 KB |